Search Results - "Lovacký, S"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    The metabolic effects of acute and chronic administration of gastrozepin by Kuhn, E, Andĕl, M, Brodan, V, Tauber, O, Veselková, A, Lovacký, S

    “…The structure of gastrozepin (G) resembles that of tricyclic antidepressants and antihistaminic and antiserotonic cyproheptadine which are compounds with known…”
    Get more information
    Journal Article
  2. 2

    Plasma beta-endorphin, bombesin and pancreatic polypeptide immunoreactivity in healthy subjects and ulcer patients and changes during treatment with pirenzepine by Lodin, Z, Zizkovský, V, Tauber, O, Dvorák, P, Srajer, J, Lovacký, S

    Published in Czechoslovak medicine (1991)
    “…A lower level of BEI was demonstrated in duodenal ulcer patients in both acute and chronic cases (P less than 0.01). Treatment of patients with PI increases…”
    Get more information
    Journal Article
  3. 3

    Mutual correlation between levels of plasma beta-endorphin, bombesin and pancreatic polypeptide in healthy subjects and ulcer patients by Zizkovský, V, Lodin, Z, Tauber, O, Srajer, J, Dvorák, P, Lovacký, S

    Published in Endocrinologia experimentalis (01-03-1990)
    “…A lower level of beta-endorphin (BE) was demonstrated in patients with both acute and chronic duodenal ulcer (P less than 0.01), while the basal level of…”
    Get more information
    Journal Article
  4. 4

    Plasma beta-endorphin immunoreactivity (PL-beta-ED-ir) in patients with ulcer disease and its management by acute and chronic administration of gastrozepin by Kuhn, E, Lodin, Z, Lovacký, S, Tauber, O, Zizkovský, V, Dvorák, P, Srajer, S, Skála, I

    Published in Hepato-gastroenterology (01-02-1986)
    “…The initial level of PL-beta-ED-ir was significantly lowered in a group of 14 patients with gastroduodenal ulcer disease as compared with healthy volunteers (P…”
    Get more information
    Journal Article
  5. 5